|
1)
The ErbB receptors and their
ligands in cancer: an overview.
Normanno N, Bianco C, Strizzi L, Mancino M,
Maiello MR, De Luca A, Caponigro F, Salomon DS.
Curr Drug
Targets. 2005
May;6(3):243-57. Review.
2)
Gefitinib inhibits the ability
of human bone marrow stromal cells to induce osteoclast differentiation:
implications for the pathogenesis and treatment of bone metastasis.
Normanno N, De Luca A,
Aldinucci D, Maiello MR, Mancino M, D'Antonio A, De Filippi R, Pinto A.
Endocr Relat
Cancer. 2005
Jun;12(2):471-82.
3)
Epidermal growth factor
receptor (EGFR) tyrosine kinase inhibitors in breast cancer: current
status and future development.
Normanno N, De Luca A, Maiello MR, Mancino M,
D'Antonio A, Macaluso M, Caponigro F, Giordano A.
Front Biosci.
2005 Sep 1;10:2611-7.
4)
Epidermal growth factor
receptor (EGFR) signaling in cancer.
Normanno N, De Luca A, Bianco C, Strizzi L,
Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS.
Gene.
2006 Jan 17;366(1):2-16. Epub 2005 Dec 27. Review.
5)
The MEK/MAPK pathway is
involved in the resistance of breast cancer cells to the EGFR tyrosine
kinase inhibitor gefitinib.
Normanno N, De Luca A, Maiello MR, Campiglio M,
Napolitano M, Mancino M, Carotenuto A, Viglietto G, Menard S.
J Cell
Physiol. 2006
May;207(2):420-7.
6)
Identification of cripto-1 as a
novel serologic marker for breast and colon cancer.
Bianco C, Strizzi L, Mancino M,
Rehman A, Hamada S, Watanabe K, De Luca A, Jones B, Balogh G, Russo J,
Mailo D, Palaia R, D'Aiuto G, Botti G, Perrone F, Salomon DS, Normanno
N.
Clin Cancer
Res. 2006 Sep
1;12(17):5158-64.
7)
Development of leiomyosarcoma
of the uterus in MMTV-CR-1 transgenic mice.
Strizzi L, Bianco C, Hirota M,
Watanabe K, Mancino M, Hamada S, Raafat A, Lawson S, Ebert AD, D'Antonio
A, Losito S, Normanno N, Salomon DS.
J Pathol.
2007 Jan;211(1):36-44.
8)
Regulation of human Cripto-1
gene expression by TGF-beta1 and BMP-4 in embryonal and colon cancer
cells.
Mancino M, Strizzi L,
Wechselberger C, Watanabe K, Gonzales M, Hamada S, Normanno N, Salomon
DS, Bianco C.
J Cell
Physiol. 2008
Apr;215(1):192-203.
9)
Breast cancer cells with
acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show
persistent activation of MAPK signaling.
Normanno N, Campiglio M, Maiello MR, De Luca A,
Mancino M, Gallo M, D'Alessio A, Menard S.
Breast
Cancer Res Treat.
2008 Nov;112(1):25-33. Epub 2007 Nov 30.
10)
Regulation of Cripto-1
signaling and biological activity by caveolin-1 in mammary epithelial
cells.
Bianco C, Strizzi L, Mancino M,
Watanabe K, Gonzales M, Hamada S, Raafat A, Sahlah L, Chang C, Sotgia F,
Normanno N, Lisanti M, Salomon DS.
Am J Pathol.
2008 Feb;172(2):345-57. Epub 2008 Jan 17.
11)
Neuronal guidance protein
Netrin-1 induces differentiation in human embryonal carcinoma cells.
Mancino M, Esposito C, Watanabe
K, Nagaoka T, Gonzales M, Bianco C, Normanno N, Salomon DS, Strizzi L.
Cancer Res.
2009 Mar 1;69(5):1717-21. Epub 2009 Feb 17.
|